Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -184.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,505.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -3,846.00 |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,078.00 |
| Jun 30, 2025 | 2,157.00 |
| Mar 31, 2025 | 1,737.00 |
| Dec 31, 2024 | 3,518.00 |
| Sep 30, 2024 | -301.00 |
| Jun 30, 2024 | -656.00 |
| Mar 31, 2024 | -1,241.00 |
| Dec 31, 2023 | -1,053.00 |
| Sep 30, 2023 | -1,897.00 |
| Jun 30, 2023 | -319.00 |
| Mar 31, 2023 | 44.00 |
| Dec 31, 2022 | 2,327.00 |
| Sep 30, 2022 | -1,374.00 |
| Jun 30, 2022 | -941.00 |
| Mar 31, 2022 | -1,493.00 |
| Dec 31, 2021 | 3,238.00 |
| Sep 30, 2021 | -684.00 |
| Jun 30, 2021 | 402.00 |
| Mar 31, 2021 | 530.00 |
| Dec 31, 2020 | 8,551.00 |